Nyxoah SA (EBR:NYXH)
3.850
-0.090 (-2.28%)
At close: Sep 26, 2025
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €144.13 million as of September 26, 2025. Its market cap has decreased by -44.39% in one year.
Market Cap
144.13M
Enterprise Value
123.54M
Revenue
4.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.85
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 144.13M, a decrease of -65.50%. That is a compound annual growth rate of -19.09%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 144.13M | -53.38% |
Dec 31, 2024 | 309.15M | 153.09% |
Dec 29, 2023 | 122.15M | -8.05% |
Dec 30, 2022 | 132.85M | -72.29% |
Dec 31, 2021 | 479.37M | 37.44% |
Dec 31, 2020 | 348.77M | -16.52% |
Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 37.53B |
UCB SA | 37.41B |
Financière de Tubize | 7.06B |
Fagron NV | 1.44B |
Ion Beam Applications | 306.13M |
Onward Medical | 221.64M |
Hyloris Pharmaceuticals | 163.52M |
Sequana Medical NV | 49.95M |